Gliclazide Milpharm

Gliclazide Milpharm Uses, Dosage, Side Effects, Food Interaction and all others data.

Gliclazide Milpharm stimulates the release of insulin from pancreatic beta-cells by facilitating Ca++ transport across the beta-cell membranes. It lowers blood glucose by stimulating the release of insulin from the pancreas, an effect dependent upon functioning beta cells in the pancreatic islets. Extrapancreatic effects also may play a part in the mechanism of action of oral sulfonylurea hypoglycemic drugs. Two extrapancreatic effects shown to be important in the action of Gliclazide Milpharm are an increase in insulin sensitivity and a decrease in hepatic glucose production. The anti-oxidant, platelet inhibiting and fibrinolytic actions of Gliclazide Milpharm involve processes which have been implicated in the pathogenesis of vascular complications of type 2 diabetes.

Based on the pharmacological properties, gliclazide is a second generation sulphonylurea which acts as a hypoglycemic agent. It stimulates β cells of the islet of Langerhans in the pancreas to release insulin. It also enhances peripheral insulin sensitivity. Overall, it potentiates insulin release and improves insulin dynamics.

Trade Name Gliclazide Milpharm
Generic Gliclazide
Gliclazide Other Names Gliclazida, Gliclazide, Gliclazidum
Formula C15H21N3O3S
Weight Average: 323.41
Monoisotopic: 323.130362722
Protein binding

94%, highly bound to plasma proteins

Groups Approved
Therapeutic Class Sulfonylureas
Manufacturer Aurobindo Pharma - Milpharm Ltd,
Available Country United Kingdom
Last Updated: September 19, 2023 at 7:00 am
Gliclazide Milpharm
Gliclazide Milpharm


Gliclazide Milpharm is used for control of blood glucose in patients with non-insulin dependent diabetes mellitus (Type-II, maturity onset diabetes mellitus) whose hyperglycemia cannot be controlled by diet alone.

Gliclazide Milpharm is also used to associated treatment for these conditions: Type 2 Diabetes Mellitus

How Gliclazide Milpharm works

Gliclazide Milpharm binds to the β cell sulfonyl urea receptor (SUR1). This binding subsequently blocks the ATP sensitive potassium channels. The binding results in closure of the channels and leads to a resulting decrease in potassium efflux leads to depolarization of the β cells. This opens voltage-dependent calcium channels in the β cell resulting in calmodulin activation, which in turn leads to exocytosis of insulin containing secretorty granules.


Gliclazide Milpharm dosage

Adult: The usual initial dose of Gliclazide Milpharmis 40 to 80 mg daily, gradually increased, if necessary up to 320 mg daily until adequate control is achieved. A single dose should not exceed 160 mg. When higher doses are required it should be taken twice daily, according to the main meals of the day. For extended release tablet the initial recommended dose is 30 mg daily, even in elderly patients (>65 years); the daily dose may vary from 30 to 120 mg taken orally, once daily.

Gliclazide Milpharm extend release tablet should be taken with food because there is increased risk of hypoglycemia if a meal is taken late. It is recommended that the medication be taken at breakfast time. If a dose is forgotten, the dose taken on the next day should not be increased. Dose titration should be carried out in steps of 30 mg, according to the fasting blood glucose response. Each step should last for at least two weeks. Gliclazide Milpharm extend release tabletshould be neither broken nor chewed. Gliclazide Milpharm extend release tablet30 mg, can replace Gliclazide Milpharm 80 mg tabletsfor doses of 1 to 4 tablets per day.

Elderly: Plasma clearance of Gliclazide Milpharm is not altered in the elderly and steady state plasma levels are similar to those in adults under 65 years. Clinical experience in the elderly shows that it is effective and well tolerated.

Children: Gliclazide Milpharm as with other sulfonylureas is not indicated for the treatment of juvenile onset diabetes mellitus.

Side Effects

Hypoglycemia may occur in concurrent conditions such as hepatic & renal diseases, alcohol intoxication and adrenal and pituitary insufficiency. Mild gastro-intestinal disturbances including nausea, dyspepsia, diarrhea, and constipation have been reported but these types of adverse reactions can be avoided if Gliclazide Milpharm is taken during a meal. Allergic dermatological reactions including rash, prurits, erythema, bullous eruption have been reported during treatment with the drug but are not known to be directly attributable to it. More serious reactions like leucopenia, thrombocytopenia, agranulocytosis, pancytopenia, hemolytic anemia, cholestatic jaundice, GI hemorrhage have not been reported with Gliclazide Milpharm.


LD50=3000 mg/kg (orally in mice). Gliclazide Milpharm and its metabolites may accumulate in those with severe hepatic and/or renal dysfunction. Symptoms of hypoglycemia include: dizziness, lack of energy, drowsiness, headache and sweating.


Gliclazide Milpharm should be used carefully in patients with hepatic impairment. If there is definite hepatic disease then gliclazide should not be used. Consucon (Gliclazide Milpharm) can be used safely in patients with renal insufficiency as it is extensively metabolized. Consucon has less sudden hypoglycaemic episode than other sulfonylurea group of drugs.


The hypoglycemic effect of Gliclazide Milpharm may be potentiated by NSAID (in particular aspirin), phenylbutazone, sulfonamides, coumarin derivatives, MAOIs, beta-adrenergic blockers, tetracyclines, chloramphenicol, clofibrate, cimetidine and miconazole tablets. Ingestion of alcohol may also increase the hypoglycemic effect of Gliclazide Milpharm. Some drugs may on the contrary, reduce its activity e.g. barbiturates, corticosteroides, thiazide diuretics, thyroid hormones, laxatives and oral contraceptives.

Food Interaction

  • Avoid alcohol.
  • Take with or without food. Consistent food intake reduces the risk of hypoglycemia.

Elimination Route

Rapidly and well absorbed but may have wide inter- and intra-individual variability. Peak plasma concentrations occur within 4-6 hours of oral administration.

Half Life

10.4 hours. Duration of action is 10-24 hours.

Elimination Route

Metabolites and conjugates are eliminated primarily by the kidneys (60-70%) and also in the feces (10-20%).

Pregnancy & Breastfeeding use

Pregnant Women: Gliclazide Milpharm should not be used in pregnant women although animal studies of Gliclazide Milpharm have not shown any teratogenic effect.

Nursing Mothers: This drug is contraindicated when breast feeding.


Hypersensitivity to sulfonylurea, diabetes complicated by ketoacidosis with coma, as a sole therapy of insulin-dependent (Type-1) diabetes mellitus, diabetes when complicated by pregnancy & breast-feeding.

Special Warning

Elderly: Plasma clearance of Gliclazide Milpharm is not altered in the elderly and steady state plasma levels are similar to those in adults under 65 years. Clinical experience in the elderly shows that it is effective and well tolerated.

Children: Gliclazide Milpharm as with other sulfonylureas is not indicated for the treatment of juvenile onset diabetes mellitus.

Acute Overdose

Symptoms: Hypoglycaemia with or without coma, convulsions or other neurological disorders.

Management: Carbohydrate intake, dosage adjustment and/or change of diet may be helpful. Admin rapid IV inj of concentrated glucose soln for hypoglycaemic coma.

Storage Condition

Store in a cool and dry place, below 30° C and away from light.

Innovators Monograph

You find simplified version here Gliclazide Milpharm

Gliclazide Milpharm contains Gliclazide see full prescribing information from innovator Gliclazide Milpharm Monograph, Gliclazide Milpharm MSDS, Gliclazide Milpharm FDA label


What is Gliclazide Milpharm used for?

Gliclazide Milpharm is a sulfonylurea type of anti-diabetic medication, used to treat type 2 diabetes. It is used when dietary changes, exercise, and weight loss are not enough.

How safe is Gliclazide Milpharm?

Gliclazide Milpharm is safe to take for a long time. There's no evidence it harms your pancreas or your general health. But Gliclazide Milpharm may stop working properly after a while. Your doctor may then want to stop it or add a different medicine to help keep your blood sugar level stable.

How does Gliclazide Milpharm work?

Gliclazide Milpharm works by increasing the amount of insulin your body makes.

What are the common side effects of Gliclazide Milpharm?

Common side effects of Gliclazide Milpharm are include:

  • stomach ache or indigestion.
  • feeling sick (nausea)
  • being sick (vomiting) or diarrhoea.
  • constipation.

Is Gliclazide Milpharm safe during pregnancy?

Gliclazide Milpharm is not generally recommended in pregnancy and while breastfeeding. It's not clear whether Gliclazide Milpharm harms an unborn baby. For safety, your doctor will probably change your medicine to insulin before you become pregnant or as soon as you find out you're pregnant.

Is Gliclazide Milpharm safe during breastfeeding?

Gliclazide Milpharm is not generally recommended in pregnancy and while breastfeeding.

Can I drink alcohol with Gliclazide Milpharm?

Yes, you can drink alcohol while taking Gliclazide Milpharm, but it's best for men and women to drink no more than 2 units a day. Drinking more than this can increase the risk of low blood sugar.

Can I drive after taking Gliclazide Milpharm?

If your blood sugar levels are stable, your ability to drive, cycle or use machines or tools should not be affected by Gliclazide Milpharm. But if your blood sugar levels become too low, this can reduce your concentration. If this happens to you, do not drive, cycle or use machines or tools until you feel better.

When should be taken of Gliclazide Milpharm?

If you take Gliclazide Milpharm once a day, it's best to take it in the morning with breakfast. Gliclazide Milpharm can sometimes make your blood sugar level too low . Carry some sweets or fruit juice with you to help when this happens.

Can I take Gliclazide Milpharm on an empty stomach?

Gliclazide Milpharm tablets should be taken before food , either with breakfast or the first main meal of the day.

How long does Gliclazide Milpharm take to work?

When taken 30 minutes before breakfast, Gliclazide Milpharm produced a peak of IRI 30 minutes after the meal; taken immediately before or after, it took twice to three times as long to produce an IRI peak.

How long does Gliclazide Milpharm last in the body?

Gliclazide Milpharm is more effective when administered about 30 minutes before a meal. Blood sugar control persists for up to 24 hours following a single dose, even though levels of Gliclazide Milpharm in the blood are barely detectable.

How often can I take Gliclazide Milpharm?

For standard-release Gliclazide Milpharm, the maximum daily dose is 320mg. If you need to take more than 160mg a day, take the tablets twice a day with your morning and evening meals.

Who should not take Gliclazide Milpharm?

Gliclazide Milpharm is only for adults. Do not give this medicine to children under 18 years.

What happen If I missed Gliclazide Milpharm?

If you missed a dose of Gliclazide Milpharm, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not take two doses together to make up for a missed dose.

What happen if I overdose of Gliclazide Milpharm?

Never take more than the prescribed dose of Gliclazide Milpharm. If you suspect that you might have taken an overdose of this medicine, go to the nearest emergency medical department/hospital.

Can Gliclazide Milpharm affects my heart ?

If you have problems with the heart and blood vessels, use Gliclazide Milpharm with caution as it can increase the risk of heart failure.

Will Gliclazide Milpharm affect my fertility?

There's no firm evidence to suggest that taking Gliclazide Milpharm will reduce fertility in either men or women.

Does Gliclazide Milpharm affect kidney function?

Gliclazide Milpharm can be considered in renal impairment if appropriate attention is paid to the dose.

Can Gliclazide Milpharm cause liver damage?

This case strongly suggests that Gliclazide Milpharm can induce acute icteric liver necro-inflammation which may be misdiagnosed clinically as acute viral hepatitis. In patients who show abnormal liver function tests, the immediate discontinuation of Gliclazide Milpharm is recommended.

*** Taking medicines without doctor's advice can cause long-term problems.